| Literature DB >> 30554356 |
Lorenzo Maggi1, Pia Bernasconi2, Adele D'Amico3, Raffaella Brugnoni2, Chiara Fiorillo4, Matteo Garibaldi5, Guja Astrea6, Claudio Bruno7, Filippo Maria Santorelli6, Rocco Liguori8,9, Giovanni Antonini5, Amelia Evoli10, Enrico Bertini3, Carmelo Rodolico11, Renato Mantegazza2.
Abstract
Congenital myasthenic syndromes (CMS) are genetic disorders due to mutations in genes encoding proteins involved in the neuromuscular junction structure and function. CMS usually present in young children, but perinatal and adult onset has been reported. Clinical presentation is highly heterogeneous, ranging from mild symptoms to severe manifestations, sometimes with life-threatening respiratory episodes, especially in the first decade of life. Although considered rare, CMS are probably underestimated due to diagnostic difficulties. Because of the several therapeutic opportunities, CMS should be always considered in the differential diagnosis of neuromuscular disorders. The Italian Network on CMS proposes here recommendations for proper CMS diagnosis and management, aiming to guide clinicians in their practical approach to CMS patients.Entities:
Keywords: Congenital myasthenic syndromes; Myasthenia gravis; Myopathy; Neuromuscular junction; Recommendations
Mesh:
Year: 2018 PMID: 30554356 DOI: 10.1007/s10072-018-3682-x
Source DB: PubMed Journal: Neurol Sci ISSN: 1590-1874 Impact factor: 3.307